首頁 > 市場調查報告書 > 醫療設備

生技設備

寡核苷酸合成市場規模、佔有率及成長分析（依產品、產品類型、應用、最終用戶及地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1900131

寡核苷酸合成市場規模、佔有率及成長分析（依產品、產品類型、應用、最終用戶及地區分類）－2026-2033年產業預測

Oligonucleotide Synthesis Market Size, Share, and Growth Analysis, By Product (Oligonucleotide, Reagents), By Type (Custom Oligos, Predesigned Oligos), By Application, By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月23日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

全球寡核苷酸合成市場規模預計在 2024 年達到 73 億美元，從 2025 年的 85.7 億美元成長到 2033 年的 309.3 億美元，在預測期（2026-2033 年）內複合年成長率為 17.4%。

全球慢性病發生率的上升趨勢，以及對醫療研發的大量投入，正在推動寡核苷酸合成的需求。精準醫療和個人化醫療的日益普及有望為合成服務提供者創造新的商機。此外，基因療法在多種疾病治療中的應用日益廣泛，以及寡核苷酸在醫療領域的應用不斷拓展，也將進一步推動這些公司的市場發展。合成技術的進步以及人們對核酸療法的日益關注，預計也將促進市場成長。北美地區由於醫療研發投入龐大，已成為主要市場之一，但高昂的合成成本、複雜的法規結構、倫理問題以及有限的生產能力等挑戰可能會抑制市場需求。

全球寡核苷酸合成市場促進因素

寡核苷酸是多種診斷技術（包括PCR、qPCR和次世代定序(NGS)）的關鍵組成部分，顯著推動了對早期診斷解決方案的需求。隨著醫療保健領域對快速準確診斷的日益重視，高品質寡核苷酸的需求預計將大幅成長。這種對早期檢測的日益關注將為寡核苷酸合成市場帶來新的成長機會，為技術進步和產能提升創造條件。因此，調查方法的不斷發展進一步凸顯了寡核苷酸合成在滿足全球人口日益成長的醫療需求方面的重要性。

限制全球寡核苷酸合成市場的因素

全球寡核苷酸合成市場面臨的主要限制因素是寡核苷酸的高生產成本，尤其是那些對治療應用至關重要的高純度或複雜結構的寡核苷酸。此外，純化過程和嚴格的品管措施也增加了整體財務負擔。這種經濟壁壘使得小規模的生技公司難以投資必要的資源並在市場中有效競爭。因此，財務限制抑制了寡核苷酸合成領域的創新和成長機會，進而影響了整個市場的擴張。

全球寡核苷酸合成市場趨勢

全球寡核苷酸合成市場正經歷著向人工智慧 (AI) 和自動化融合的動態轉變，這顯著改變了合成流程。這一趨勢提高了寡核苷酸生產的準確性和擴充性，從而實現了更精準、更有效率的生產。自動化合成儀和 AI 驅動的設計工具不僅提高了營運效率，還有助於大幅降低成本，使高品質寡核苷酸更容易獲得。隨著研究需求的成長以及基因組學和個人化醫療等領域應用的不斷擴展，這些先進技術的應用預計將加速發展，從而推動產業創新和競爭優勢的形成。因此，在這些技術進步的驅動下，市場可望強勁成長。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Thermo Fisher Scientific（USA）
Merck KGaA（Germany）
Agilent Technologies（USA）
LGC Biosearch Technologies（UK）
Integrated DNA Technologies（IDT）（USA）
Eurofins Genomics（Luxembourg）
GenScript Biotech Corporation（USA）
Twist Bioscience（USA）
Bio-Synthesis Inc.（USA）
ATUM（USA）
DNA Script（France）
SGI-DNA（USA）
Eurogentec（Kaneka）（Belgium）
Creative Biogene（USA）
GeneCust Europe（Luxembourg）
Synbio Technologies（USA）
Epoch Life Science, Inc.（USA）
Bioneer Corporation（South Korea）
Genewiz（Azenta Life Sciences）（USA）

結論與建議

簡介目錄

Product Code: SQMIG35H2107

Global Oligonucleotide Synthesis Market size was valued at USD 7.30 Billion in 2024 and is poised to grow from USD 8.57 Billion in 2025 to USD 30.93 Billion by 2033, growing at a CAGR of 17.4% during the forecast period (2026-2033).

The growing incidence of chronic diseases globally, coupled with significant investments in medical research and development, is driving the demand for oligonucleotide synthesis. The surge in popularity of precision and personalized medicine is expected to present new business opportunities for synthesis providers. Additionally, the increasing acceptance of gene therapies for various conditions and the expanding applications of oligonucleotides across healthcare sectors will further enhance opportunities for these companies. Advancements in synthesis technologies and a rising focus on nucleic acid-based therapeutics are also projected to contribute to market growth. North America stands out as a leading market due to substantial healthcare research spending, though challenges such as high synthesis costs, complex regulatory frameworks, ethical concerns, and limited manufacturing capacities could hinder demand.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Oligonucleotide Synthesis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Oligonucleotide Synthesis Market Segments Analysis

Global Oligonucleotide Synthesis Market is segmented by Product, Type, Application, End User and region. Based on Product, the market is segmented into Oligonucleotide, Reagents and Equipment. Based on Type, the market is segmented into Custom Oligos and Predesigned Oligos. Based on Application, the market is segmented into Therapeutic Applications, Diagnostics, Research and Others. Based on End User, the market is segmented into Academic Research Institutes, Pharmaceutical and Biotechnology Companies,, Diagnostic Laboratories and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Oligonucleotide Synthesis Market

Oligonucleotides are essential components in various diagnostic technologies like PCR, qPCR, and next-generation sequencing (NGS), driving a significant demand for early diagnostic solutions. As the healthcare landscape increasingly prioritizes swift and accurate diagnostics, the need for high-quality oligonucleotides is expected to surge. This growing emphasis on early detection is likely to unlock new avenues for growth within the oligonucleotide synthesis market, presenting opportunities for advancements in technology and increased production capabilities. Consequently, the ongoing evolution of diagnostic methodologies further underscores the importance of oligonucleotide synthesis in meeting the rising healthcare needs of the global population.

Restraints in the Global Oligonucleotide Synthesis Market

The Global Oligonucleotide Synthesis market faces constraints primarily due to the high costs associated with producing oligonucleotides, particularly those with high purity or complex structures essential for therapeutic use. Additionally, the expenses related to purification processes and rigorous quality control measures contribute to the overall financial strain. This economic barrier results in limited accessibility for smaller biotechnology companies, which may struggle to invest in the necessary resources to compete effectively in the market. Consequently, the financial limitations hinder innovation and growth opportunities within the oligonucleotide synthesis sector, affecting the overall expansion of the market.

Market Trends of the Global Oligonucleotide Synthesis Market

The Global Oligonucleotide Synthesis market is experiencing a dynamic shift towards the integration of artificial intelligence and automation, significantly transforming synthesis processes. This trend enhances the accuracy and scalability of oligonucleotide production, enabling more precise and efficient manufacturing. Automated synthesizers and AI-driven design tools not only streamline operations but also contribute to substantial cost reductions, making high-quality oligonucleotides more accessible. As research demands grow and applications in genomics and personalized medicine expand, the adoption of these advanced technologies is expected to accelerate, driving innovation and competitive advantage within the sector. Consequently, the market is poised for robust growth propelled by these technological advancements.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Analysis

Global Oligonucleotide Synthesis Market Size by Product & CAGR (2026-2033)

Market Overview
Oligonucleotide
- DNA
- Column-based
- Array-based
- RNA
- Technology
- Column-based
- Array-based
- Type
- Short RNA Oligos (< 65 nt)
- Long RNA Oligos (> 65 nt)
- CRISPR (sgRNA)
Reagents
Equipment

Global Oligonucleotide Synthesis Market Size by Type & CAGR (2026-2033)

Market Overview
Custom Oligos
Predesigned Oligos

Global Oligonucleotide Synthesis Market Size by Application & CAGR (2026-2033)

Market Overview
Therapeutic Applications
Diagnostics
Research
Others

Global Oligonucleotide Synthesis Market Size by End User & CAGR (2026-2033)

Market Overview
Academic Research Institutes
Pharmaceutical and Biotechnology Companies,
Diagnostic Laboratories
Others

Global Oligonucleotide Synthesis Market Size & CAGR (2026-2033)

North America (Product, Type, Application, End User)
- US
- Canada
Europe (Product, Type, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Type, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Type, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Type, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Thermo Fisher Scientific (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LGC Biosearch Technologies (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Integrated DNA Technologies (IDT) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins Genomics (Luxembourg)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GenScript Biotech Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Twist Bioscience (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Synthesis Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ATUM (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DNA Script (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SGI-DNA (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurogentec (Kaneka) (Belgium)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Creative Biogene (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GeneCust Europe (Luxembourg)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Synbio Technologies (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Epoch Life Science, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bioneer Corporation (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genewiz (Azenta Life Sciences) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments